OncoTracker Expands Multiple Myeloma Intellectual Property

WEST HOLLYWOOD, Calif., March 12, 2019 /PRNewswire/ — ONCOtracker, Inc. announced that it has strengthened its intellectual property portfolio in multiple myeloma by completing an agreement with the Institute for Myeloma and Bone Cancer Research to acquire worldwide...

OncoTracker CEO to Speak at 20th Annual SoCalBio Conference

WEST HOLLYWOOD, Calif., Sept. 24, 2018 /PRNewswire/ — OncoTracker, Inc. announced that its Chief Executive Officer, James Kuo, MD, MBA, has been invited to speak at the 20th Annual SoCalBio Conference taking place on Friday, September 28, 2018. Dr. Kuo will provide an...